Windlas Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2025 and to consider recommendation of dividend, if any.